26th Jan 2007 17:04
Sinclair Pharma PLC26 January 2007 Sinclair Pharma plc NOTIFICATION OF MAJOR INTERESTS IN SHARES 26 January 2007, Godalming, UK: Sinclair Pharma plc ("Sinclair" or "the Company") was informed on 25 January 2007 that, as at close of business on 24January 2007, AXA S.A. was deemed interested in a total of 11,689,078 ordinaryshares of 1 pence each of the Company, representing 12.52% of the current issuedshare capital. These shares represent a beneficial interest of 3,115,000 shares(3.34%) and a non-beneficial interest of 8,574,078 shares (9.18%). This notification is due to an increase in the beneficial interest holding from0.00% to 3.34%. - ends - For further information please contact: Sinclair Pharma plc Tel: +44 (0) 1483 410 600Dr Michael Flynn, CEOZoe McDougall, Director of Communications UKCapital MS&LMary Clark, Halina Kukula Tel +44 (0)20 7307 5340 Other languages For versions of this press release in German, French, Spanish or Japanese pleasecontact [email protected] "Safe Harbor" Statement under the US Private Securities Litigation Reform Act of1995: Some or all of the statements in this document that relate to futureplans, expectations, events, performances and the like are forward-lookingstatements, as defined in the US Private Securities Litigation Reform Act of1995. Actual results of events could differ materially from those described inthe forward- looking statements due to a variety of factors. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma